Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 34

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 34
---
 StatementsJune 30, 2025(Unaudited)

factors, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.During the three and six months ended June 30, 2025 and 2024, we repurchased no common stock. At June 30, 2025, $353.4 million remained unused under the 2022 Authorization.

Note 11: Restructuring and Other (Income) Charges, net

Detail on the restructuring charges and other (income) charges, net, is provided below.Three Months Ended June 30,Six Months Ended June 30,In millions2025202420252024Restructuring charges$21.9 $10.0 $34.2 $72.3 Other (income) charges, net— 3.1 — 3.6 Total Restructuring and other (income) charges, net$21.9 $13.1 $34.2 $75.9 Restructuring ChargesIn millionsSeverance and other employee-related costsOther charges (income) (1)Asset disposal charges (2)TotalPerformance Chemicals repositioning$— $8.9 $3.3 $12.2 Other (3)1.7 3.7 4.3 9.7 Three Months Ended June 30, 2025$1.7 $12.6 $7.6 $21.9 Performance Chemicals repositioning$1.0 $7.2 $1.8 $10.0 Three Months Ended June 30, 2024$1.0 $7.2 $1.8 $10.0 In millionsSeverance and other employee-related costsOther charges (income) (1)Asset disposal charges (2)TotalPerformance Chemicals repositioning$— $20.1 $3.2 $23.3 Other (3)2.5 4.0 4.4 10.9 Six Months Ended June 30, 2025$2.5 $24.1 $7.6 $34.2 Performance Chemicals repositioning$3.1 $12.4 $56.8 $72.3